Trial intelligence / Profile preview

Noradrenaline vs Glypressin for Hypotension in Knee Arthroplasty

NCT05774067Completed

Sponsor
Tanta University
Start
Dec 2022
Primary completion
Jun 2023
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Randomised trial of terlipressin in hypotension (3 arms), sponsored by Tanta University. Primary endpoint: Change of Mean Arterial Blood Pressure. Started Dec 2022; status: completed.

02

Drugs

terlipressin
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT05774067.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05774067.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call